Course Access
- This topic has 0 replies, 1 voice, and was last updated 4 years ago by
.
-
Posts
-
EOI Deadline extended to 0900 Wednesday 4th November 2020
The National Covid-19 Clinical Evidence Taskforce new IPC Panel
The National Covid-19 Clinical Evidence Taskforce is undertaking continuous
evidence surveillance to identify and rapidly synthesise emerging research
in order to provide national, evidence-based guidelines for the clinical
care of people with COVID-19.They are now calling for Expressions of Interest from suitably qualified
individuals to join the new Infection Prevention and Control (IPC) Panel.The Panel is a collaboration between the Taskforce and Infection Control
Expert Group (ICEG), and will be jointly Co-Chaired by one representative
nominated by ICEG and one representative nominated by the Taskforce. Full
details located in the document attached.Deadline for EOI extended to 0900 Wednesday 4th November
Kind regards,
Sara Kirby
Australasian Office Manager
+61 3 6281 9239
0429 294 033
228 Liverpool Street, Hobart TAS 7000, Australia
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
- The forum ‘Infexion Connexion’ is closed to new topics and replies.